Eric D Adler

Title: Eric D Adler: Innovator in Gene Therapy for Lysosomal Disorders

Introduction

Eric D Adler is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of gene therapy, particularly in the treatment of lysosomal disorders. With a total of 2 patents, his work focuses on innovative methods that aim to improve the lives of individuals affected by these conditions.

Latest Patents

One of Eric's latest patents is titled "Methods of treating lysosomal disorders." This patent outlines methods for treating a lysosomal transmembrane protein disease or disorder through the ex vivo introduction of a nucleic acid molecule into hematopoietic stem and progenitor cells (HSPCs). Following this introduction, the HSPCs are transplanted into a subject in need of treatment. Additionally, the patent provides vectors containing the nucleic acid molecule. Another significant patent is "Methods for the treatment of Danon disease and other disorders of autophagy." This disclosure presents gene therapy vectors comprising a polynucleotide encoding one or more isoforms of lysosome-associated membrane protein 2 (LAMP-2). It also details methods of using these gene therapy vectors for the treatment of Danon disease and other autophagy disorders.

Career Highlights

Eric D Adler is affiliated with the University of California, where he continues to advance research in gene therapy. His work has garnered attention for its potential to transform treatment options for patients suffering from lysosomal disorders.

Collaborations

Eric collaborates with esteemed colleagues, including Stephanie Cherqui and Sylvia Evans, who contribute to the research and development of innovative therapies in this field.

Conclusion

Eric D Adler's contributions to gene therapy represent a significant advancement in the treatment of lysosomal disorders. His innovative methods and collaborative efforts continue to pave the way for future breakthroughs in medical science.